Qiagen NV | QIA - Interest Income

Stock Price
43.18
Daily Change
-0.30 -0.69%
Monthly
1.92%
Yearly
8.88%
Q1 Forecast
43.53

Qiagen NV reported $15.07M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
argenx SE USD 38.4M 1.28M Jun/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 13M 3M Sep/2025
Moderna USD 81M 9M Jun/2025
Qiagen NV USD 15.07M 1.21M Sep/2025
Revvity USD 0.4 8.34M Sep/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025